Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer
Yifan Feng(Shanxi Medical University), Tiantai Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hai‐Yu Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Chengjuan Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Lei Wu, Anqi Shao(Columbia University)
Cited by 29
Related Papers
Angiopoietin1/TIE2 and VEGF/FLK1 Induced by MSC Treatment Amplifies Angiogenesis and Vascular Stabilization after Stroke
|Journal of Cerebral Blood Flow & Metabolism|2007|302
IntraLase Femtosecond Laser vs Mechanical Microkeratomes in LASIK for Myopia: A Systematic Review and Meta-analysis
|Journal of Refractive Surgery|2012|155
A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs
|Bioorganic & Medicinal Chemistry|2019|136
Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity
|Bioorganic Chemistry|2018|132
Neural Progenitor Cells Treated with EPO Induce Angiogenesis through the Production of Vegf
|Journal of Cerebral Blood Flow & Metabolism|2008|129